30.11.2017
- In a provisional ruling announced on Nov. 21, the UK’s Competition and Markets Authority (CMA) has found that Canadian pharma Concordia abused its dominant position to overcharge...
25.05.2017
- The UK’s Competition and Markets Authority (CMA) has provisionally ruled that a discount scheme operated by US drugmaker Merck for Remicade may have broken competition rules by...
09.03.2017
- The UK’s Competition and Markets Authority (CMA) has accused Concordia and Actavis UK of breaking competition law by agreeing to delay competition and keeping the price of...
20.02.2017
- US drugs giant Pfizer has challenged the record £84 million fine imposed by the UK’s Competition and Markets Authority (CMA) for a supply scheme that resulted in a 2,600% price...
08.12.2016
- US pharmaceutical major Pfizer has been fined a record £84.2 million by the UK’s competition authority for overcharging the National Health Service (NHS) for an anti-epilepsy drug...
